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LETTER TO THE EDITOR

Very Late Stent Thrombosis:
Is There Any Limit, When to
Stop Antiplatelet Therapy?
Sir,

The advent of stent implantation has dramatically
changed the management of coronary artery disease
(CAD).1 However, this management modality brought
with it, a number of issues like stent thrombosis (STh)
and in-stent restenosis (ISR), apart from procedural
complications and financial burden. Although the issue
of ISR was, to a great extent, resolved with the
introduction of drug eluting stents (DES), very late stent
thrombosis (VLST) still occurs from time to time,
especially with first generation DES, due to delayed and
ineffective endothelialization.2
A 72-year patient with hypertension, diabetes mellitus
and prior percutaneous implentaion (PCI) of left anterior
descending (LAD) artery with SES (CYPHER®) (3.0 x 28)
more than eight and a half years ago, presented to our
emergency department with acute anterior wall ST
elevation myocardial infarction (STEMI). He was on
single antiplatelet drug (Clopidogrel, 75 mg daily) which
too was stopped by his physician 4 days prior to the
current event, due to an episode of melena.
His emergency coronary angiography showed total
occlusion of LAD with thrombus and mild plaquing in the
rest of coronary arteries (Figure 1).

LAD thrombus was aspirated, followed by intravascular
ultrasound (IVUS) which showed advanced positive
remodeling, unapposed stent in proximal and mid
portion and moderate ISR at the distal edge of the stent
(Figure 2). The proximal to mid portion of stent was postdilated and a DES (Xience-V) (Abbott®) was deployed
to cover the ISR at the distal edge (Figure 3). Post-stent
deployment, IVUS showed well apposed stent.

Figure 1: Still image of coronary angiogram
showing total occlusion of proximal left anterior
descending (LAD) artery and mild plaquing in left
circumflex (LCX) artery.
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Although, VLST is a rare phenomenon in the modern era
of advanced and sophisticated stent implantation techniques, equipment, dual antiplatelet drugs and reverse
remodeling therapy, it does occur, more commonly in
patients who discontinue their antiplatelet therapy.3 It is
relatively common with first generation DES, especially
SES (CYPHER®) because of severe inflammatory
response in the form of eosinophils, lymphocytes and
giant cells, leading to significant positive remodeling and
malapposition.4 The same occurred in our case too.

Thus, it is very important for health professionals to keep
in mind, VLST in patients having SES. If it is necessary
to stop antiplatelet therapy due to some reason, physicians
should vigilantly monitor such patients and should readminister antiplatelet therapy as soon as possible.
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Figure 2: Still image of the intravascular ultrasound of left anterior descending (LAD) artery
showing unapposed stent and positive remodeling.

Figure 3: Still image of coronary angiogram after
stent implantation showing patent left anterior
descending (LAD) artery.
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